A Clinical Study to see the effect of Febrikid Suspension in Fever in children.

A single arm clinical study to evaluate the antipyretic effect Of Febrikid Suspension in Febrile Children.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041681

Enrollment

Registered

2022-04-06

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B999- Unspecified infectious disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient of either gender suffering from fever of age 3-10 years. 2. Acute onset of fever of 1 to 3 days. 3. Temperature between 99-102 Fahrenheit. 4. Children with parents who agree to participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Fever more than 102 Fahrenheit. 2. Chronic fever associated with infective disorder. 3. Fever more than 3 days and diagnosed with malaria, dengue, typhoid, pneumonia etc. 4. Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by the investigator as non induceable will be excluded from study.

Design outcomes

Primary

Measure	Time frame
Relief in FeverTimepoint: 5 Days	—

Secondary

Measure	Time frame
To assess improvement in associated symptoms of Fever according to Ayurveda Classics everyday.Timepoint: 5 Days	—

Countries

India

Contacts

Public ContactDr Sudhir Kumar Pani

Parul Institute of Ayurveda

drsudhirpani@gmail.com9408707703

Outcome results